Oxford Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Oxford Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-36,300	Closed	-$1.5M	–	805
2015 Q2	$1.5M	Buy	+36,300	New	+$1.3M	0.04%	383
2014 Q3	–	Sell	-24,810	Closed	-$750K	–	840
2014 Q2	$750K	Buy	+24,810	New	+$685K	0.02%	528
2013 Q4	–	Sell	-131,633	Closed	-$3.93M	–	897
2013 Q3	$3.93M	Buy	131,633 +105,537	+404%	+$2.94M	0.09%	297
2013 Q2	$750K	Buy	+26,096	New	+$719K	0.02%	632

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Oxford Asset Management's BRLI Position: Q3 2015 in Review

Oxford Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 36,300 shares — an estimated $1.5M sold.

Oxford Asset Management first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $3.93M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Oxford Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Oxford Asset Management sold 36,300 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.5M.
Oxford Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
Oxford Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $3.93M in Q3 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Oxford Asset Management's 13F filing for Q3 2015, filed 14 Oct 2015.